INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 427m ago
HOUSE PTR27m ago
SEC 13F27m ago
ROBINHOOD CHAIN27m ago
Public company

SERASERA PROGNOSTICS, INC.

CIK 0001534969

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells0 / 12
Max Insider Score40
Connections9with evidence

SERA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
ID
Inglis Tiffany Eul DavisChief Medical Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$16K
8,024 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 8071 · Services-Medical Laboratories · Nov 4, 2026
  • ← Insider ofevidence
    Jackson BenjaminGeneral Counsel · Sep 11, 2026
  • ← Insider ofevidence
    Gleason ScottChief Financial Officer · Sep 1, 2026
  • ← Insider ofevidence
    Inglis Tiffany Eul DavisChief Medical Officer · Jun 15, 2026
32
LZ
Lindgardt ZhenyaDirector, Chief Executive Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL
$14K
7,022 sh
Sep 10, 2026
Sep 11, 2026
traded Sep 10, 2026
+1d
SEC FORM 4

Evidence

32
AL
Anderson Dyaarl Lee Jr.Chief Commercial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$3,600
1,800 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

32
ID
Inglis Tiffany Eul DavisChief Medical Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$972
486 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

36
JB
Jackson BenjaminGeneral Counsel
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$4,380
2,190 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

32
LZ
Lindgardt ZhenyaDirector, Chief Executive Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$40K
20.1K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

9
GS
Gleason ScottChief Financial Officer
SERASERA PROGNOSTICS, INC.
Grant or award
A—
169.6K sh
Aug 31, 2026Sep 1, 2026
traded Aug 31, 2026
+1dSEC FORM 4

Evidence

9
GS
Gleason ScottChief Financial Officer
SERASERA PROGNOSTICS, INC.
Grant or award
A—
117.9K sh
Aug 31, 2026Sep 1, 2026
traded Aug 31, 2026
+1dSEC FORM 4

Evidence

32
LZ
Lindgardt ZhenyaDirector, Chief Executive Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$14K
6,990 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

32
AA
Aerts AustinChief Financial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$4,094
2,037 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

36
ID
Inglis Tiffany Eul DavisChief Medical Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$728
362 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

40
AL
Anderson Dyaarl Lee Jr.Chief Commercial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$9,525
4,739 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

36
AA
Aerts AustinChief Financial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$11K
5,440 sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC FORM 4

Evidence

36
LZ
Lindgardt ZhenyaDirector, Chief Executive Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$43K
20.8K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC FORM 4

Evidence

9
AL
Anderson Dyaarl Lee Jr.Chief Commercial Officer
SERASERA PROGNOSTICS, INC.
Grant or award
A$5,829
3,168 sh
May 29, 2026Jun 1, 2026
traded May 29, 2026
+3dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Lindgardt ZhenyaDirector, Chief Executive Officer · Jun 10, 2026
  • ← Insider ofevidence
    Aerts AustinChief Financial Officer · Jun 10, 2026
  • ← Insider ofevidence
    Anderson Dyaarl Lee Jr.Chief Commercial Officer · Jun 1, 2026
  • ← Insider ofevidence
    Boniface John J.Chief Scientific Officer · May 6, 2026
  • ← Insider ofevidence
    Kearney PaulChief Data Officer · May 6, 2026